Showing results (31-40 of 141) with videos related to

Sort By:
Pageof 15
Journal of Clinical Medicine|November 25, 2023
Drug Clearance in Patients with Inflammatory Bowel Disease Treated with BiologicsTina Deyhim, Adam S Cheifetz, Konstantinos Papamichael
World Journal of Gastroenterology|June 11, 2014
Helicobacter pylori infection and inflammatory bowel disease: is there a link?Konstantinos Papamichael, Panagiotis Konstantopoulos, Gerassimos J Mantzaris
Alimentary Pharmacology & Therapeutics|February 15, 2022
Review article: emerging drug therapies in inflammatory bowel diseaseLaurie B Grossberg, Konstantinos Papamichael, Adam S Cheifetz
Therapeutic Drug Monitoring|April 4, 2023
Challenges in Therapeutic Drug Monitoring: Optimizing Biological Treatments in Patients With Inflammatory Bowel Disease and Other Immune-Mediated Inflammatory DiseasesKonstantinos Papamichael, Gabriele Stocco, Ainhoa Ruiz Del Agua
Gastroenterology Clinics of North America|May 20, 2022
Therapeutic Drug Monitoring of Biologics in Crohn's DiseaseLaurie B Grossberg, Adam S Cheifetz, Konstantinos Papamichael
Expert Opinion on Drug Safety|January 23, 2016
A safety assessment of anti-tumor necrosis factor alpha therapy for treatment of Crohn's diseaseKonstantinos Papamichael, Gerassimos J Mantzaris, Laurent Peyrin-Biroulet
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|April 24, 2025
Eosinophils but not mast cells exert anti-tumorigenic activity, without being predictive markers of the long-term response to Bacillus Calmette-Guérin (BCG) therapy in patients with bladder carcinomaIlan Zaffran, Yara Zoabi, Pratibha Gaur, et al.
Journal of Crohn'S & Colitis|March 20, 2012
Adalimumab for the prevention and/or treatment of post-operative recurrence of Crohn's disease: a prospective, two-year, single center, pilot studyKonstantinos Papamichael, Emmanuel Archavlis, Constantina Lariou, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 8, 2019
How, When, and for Whom Should We Perform Therapeutic Drug Monitoring?Severine Vermeire, Erwin Dreesen, Konstantinos Papamichael, et al.
European Journal of Gastroenterology & Hepatology|June 16, 2009
Low prevalence of antibodies to cyclic citrullinated peptide in patients with inflammatory bowel disease regardless of the presence of arthritisKonstantinos Papamichael, Alexandra Tsirogianni, Chryssa Papasteriades, et al.
Pageof 15